Found: 13
Select item for more details and to access through your institution.
Feasibility, Tolerability and Efficacy of Carfilzomib in Combination with Lenalidomide and Dexamethasone in Relapsed Refractory Myeloma Patients: A Retrospective Real-Life Survey of the Sicilian Myeloma Network.
- Published in:
- Journal of Clinical Medicine, 2019, v. 8, n. 6, p. 877, doi. 10.3390/jcm8060877
- By:
- Publication type:
- Article
Additional Genetic Alterations and Clonal Evolution of MPNs with Double Mutations on the MPL Gene: Two Case Reports.
- Published in:
- Hematology Reports, 2023, v. 15, n. 2, p. 317, doi. 10.3390/hematolrep15020033
- By:
- Publication type:
- Article
Therapeutic innovation for multi-resistant candidemics: Synergy of isavuconazole and caspofungin association.
- Published in:
- Hematology Reports, 2021, v. 13, n. 4, p. 1, doi. 10.4081/hr.2021.9329
- By:
- Publication type:
- Article
Off-Label Use of Venetoclax in Patients With Acute Myeloid Leukemia: Single Center Experience and Data From Pharmacovigilance Database.
- Published in:
- Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.748766
- By:
- Publication type:
- Article
Handheld Ultrasound or Conventional Ultrasound Devices in Patients Undergoing HCT: A Validation Study.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 2, p. 520, doi. 10.3390/jcm12020520
- By:
- Publication type:
- Article
Prediction of Survival and Prognosis Migration from Gold-Standard Scores in Myelofibrosis Patients Treated with Ruxolitinib Applying the RR6 Prognostic Model in a Monocentric Real-Life Setting.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 24, p. 7418, doi. 10.3390/jcm11247418
- By:
- Publication type:
- Article
Response Assessment to Erythropoietin-Zeta (Epo-Alpha Biosimilar) Therapy in Low-Risk Myelodysplastic Syndromes.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 6, p. 1665, doi. 10.3390/jcm11061665
- By:
- Publication type:
- Article
Endothelial Dysfunction after Hematopoietic Stem Cell Transplantation: A Review Based on Physiopathology.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 3, p. 623, doi. 10.3390/jcm11030623
- By:
- Publication type:
- Article
Prevention and Treatment of Acute Myeloid Leukemia Relapse after Hematopoietic Stem Cell Transplantation: The State of the Art and Future Perspectives.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 1, p. 253, doi. 10.3390/jcm11010253
- By:
- Publication type:
- Article
Role of Serum Free Light Chain Assay in Relapsed/Refractory Multiple Myeloma. A Real-Life Unicentric Retrospective Study.
- Published in:
- Cancers, 2021, v. 13, n. 23, p. 6017, doi. 10.3390/cancers13236017
- By:
- Publication type:
- Article
Assessment of the efficacy and tolerability of ruxolitinib for the treatment of myelofibrosis patients in a real‐life setting: An Italian MYNERVA Project.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 7, p. 8166, doi. 10.1002/cam4.5618
- By:
- Publication type:
- Article
Belantamab Mafodotin and Relapsed/Refractory Multiple Myeloma: This Is Not Game Over.
- Published in:
- Acta Haematologica, 2024, v. 147, n. 4, p. 493, doi. 10.1159/000521112
- By:
- Publication type:
- Article
Multiple Myeloma in 2023 Ways: From Trials to Real Life.
- Published in:
- Current Oncology, 2023, v. 30, n. 11, p. 9710, doi. 10.3390/curroncol30110705
- By:
- Publication type:
- Article